• Home
  • About
  • Contact Us
  • Infectious Disease Threats
  • Health and Wellness
  • Specialty Pharma
  • Technology
  • For Employers
  • Resources
  • Company Blogs
  • News

World's FIRST and ONLY COVID-19 Urine Antibody Rapid Test

  • Rapid Antibody Test measures the presence of COVID-19 antibodies in the urine.
  • 97.7% sensitivity, 100% specificity in recent evaluation using well characterized samples
  • 15 minutes to result
  • Detects IgM and IgG antibodies which indicate active immunity.
  • Works with symptomatic or asymptomatic individuals.
  • Easy to use, no equipment needed
  • Takes less than 2 minutes to administer
  • Colloidal gold method with proprietary enhancements to performance
  • US FDA EUA in process
  • CE Mark
  • This one-step test is easily performed by anyone, anywhere, especially at home, with the first urine in the morning.
Novel strategy to eliminate COVID-19: Immunity Test
  • This test identifies people who have been vaccinated or who have been infected and therefore have antibodies that indicate protection against the virus.
  • Since vaccine supply will not meet demand for the foreseeable future, this test is essential to identify people who have already been exposed to COVID-19 and therefore do not need immediate vaccination. After vaccination, frequent testing indicates when the natural production of antibodies is no longer protective. Once identified, vaccination can take place. This way, the vaccine supply can be stretched and conserved for those who do not test positive for protective antibodies.​
Digital Health Solutions
  • A QR code is on each test – We offer a digital application to health authorities and individuals to immediately collect the results (positive, negative, asymptomatic) from the entire population. The app will assist in the reading of results. If immunity has been lost, the app can also assist in the process of obtaining a booster shot.
Uses
Back-to-Work and Back-to-School Safety ProgramsVaccine need determinatorVaccine efficacy and longevity determinatorGeographic immunity mapping
Contact us at info@akers.biz or +1 (856) 204-2100 for pricing and availability information.
Akers Nanotechnology
+1 (856) 204-2100 info@akers.biz 286 Mantua Grove Rd Bldg 8 West Deptford, NJ 08066 USA
About Contact Infectious Disease Threats Health and Wellness Specialty Pharma Technology For Employers Resources Blogs News
FDA REG: 3016696612New Jersey Drug and Medical Device Registration: 5005855CAGE CODE: 8RFL6NAICS CODES: 541713, 423450UEI: CK8WFQTLYMV9Capability StatementCorporate Profile

Akers Nanotechnology values your privacy online. Our website uses cookies to enhance your user experience. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.